{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:52:31Z","timestamp":1781981551371,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009526","name":"Amrita Vishwa Vidyapeetham University","doi-asserted-by":"publisher","award":["Amrita Vishwa Vidyapeetham University"],"award-info":[{"award-number":["Amrita Vishwa Vidyapeetham University"]}],"id":[{"id":"10.13039\/100009526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12288-025-02130-8","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T03:26:18Z","timestamp":1757301978000},"page":"1366-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating Normal Reference Interval for Soluble B-Cell Maturation Antigen Levels in Adults: A Prospective Study from a Tertiary Care Center in Southern India"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-8269","authenticated-orcid":false,"given":"G. S","family":"Reshmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajitha","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3021-2231","authenticated-orcid":false,"given":"Manoj","family":"Unni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1925-8349","authenticated-orcid":false,"given":"Georg","family":"Gutjahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3842-9514","authenticated-orcid":false,"given":"Merin","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arundhathy","family":"Soman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-8104","authenticated-orcid":false,"given":"Neeraj","family":"Sidharthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"Suppl 2","key":"2130_CR1","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.htct.2022.02.002","volume":"45","author":"A Ismaeel","year":"2023","unstructured":"Ismaeel A, Farid E, Majed KS, Mansoor EJ, Toorani J, Tufail F et al (2023) Hematologic malignancies of primary bone marrow involvement: A decade\u2019s experience in Bahrain. Hematol Transfus Cell Ther 45(Suppl 2):S68\u201375. https:\/\/doi.org\/10.1016\/j.htct.2022.02.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"2130_CR2","unstructured":"Indian Council of Medical Research. Consensus document for management of Multiple Myeloma. New Delhi: ICMR (2017) https:\/\/www.medbox.org\/document\/consensus-document-for-management-of-multiple-myelo. subordinate document. Accessed January 2025"},{"issue":"12","key":"2130_CR3","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","volume":"125","author":"J Corre","year":"2015","unstructured":"Corre J, Munshi N, Avet-Loiseau H (2015) Genetics of multiple myeloma: another heterogeneity level? Blood 125(12):1870\u20131876. https:\/\/doi.org\/10.1182\/blood-2014-10-567370","journal-title":"Blood"},{"key":"2130_CR4","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1200\/edbk_159009","volume":"36","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV (2016) Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book 36:e418\u2013e423. https:\/\/doi.org\/10.1200\/edbk_159009","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2130_CR5","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software Version 8.4.4 \u2013 October 8, 2024. Available from: https:\/\/seer.cancer.gov"},{"key":"2130_CR6","doi-asserted-by":"publisher","unstructured":"Unnikrishnan A, Khan AM, Narayan P, Norkin M (2017) Striking age differences of multiple myeloma (MM) diagnosis in patients of Indian and Pakistani descent in the united States compared to native countries. J Clin Oncol 35. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.e13070","DOI":"10.1200\/JCO.2017.35.15_suppl.e13070"},{"issue":"16","key":"2130_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3329\/jemc.v8i3.38366","volume":"1","author":"P Kaur","year":"2014","unstructured":"Kaur P, Shah BS, Baja P (2014) Multiple myeloma: a clinical and pathological profile. Gulf J Oncol 1(16):14\u201320. https:\/\/doi.org\/10.3329\/jemc.v8i3.38366","journal-title":"Gulf J Oncol"},{"issue":"1","key":"2130_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4103\/ijc.ijc_87_17","volume":"54","author":"LA Jacob","year":"2017","unstructured":"Jacob LA, Suresh BMC, Lakshmaiah KC, Babu KG, Lokanatha D, Rajeev LK et al (2017) Multiple myeloma: experience of an Institute in a limited resource setting. Indian J Cancer 54(1):340\u2013342. https:\/\/doi.org\/10.4103\/ijc.ijc_87_17","journal-title":"Indian J Cancer"},{"issue":"3","key":"2130_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bjh.16674","volume":"191","author":"O Langseth","year":"2020","unstructured":"Langseth O, Myklebust TA, Johannesen TB, Hjertner \u00d8, Waage A (2020) Incidence and survival of multiple myeloma: a population-based study of 10,524 patients diagnosed 1982\u20132017. Br J Haematol 191(3):418\u2013425. https:\/\/doi.org\/10.1111\/bjh.16674","journal-title":"Br J Haematol"},{"key":"2130_CR10","doi-asserted-by":"publisher","unstructured":"Pydi VR, Bala SC, Kuruva SP, Chennamaneni R, Konatam ML, Gundeti S Multiple myeloma in young adults: a single center real-world experience. Indian J Hematol Blood Transfus 2021 Oct 1:1\u20135. https:\/\/doi.org\/10.1007\/s12288-021-01410-3","DOI":"10.1007\/s12288-021-01410-3"},{"key":"2130_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1200\/go.20.00625","volume":"7","author":"U Yanamandra","year":"2021","unstructured":"Yanamandra U, Sharma R, Shankar S, Yadav S, Kapoor R, Pramanik S et al (2021) Survival outcomes of newly diagnosed multiple myeloma at a tertiary care center in North India (Image: 001A Study). JCO Glob Oncol 7:704\u2013715. https:\/\/doi.org\/10.1200\/go.20.00625","journal-title":"JCO Glob Oncol"},{"issue":"10","key":"2130_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clml.2021.04.013","volume":"21","author":"S Bird","year":"2021","unstructured":"Bird S, Cairns D, Menzies T, Boyd K, Davies F, Cook G et al (2021) Sex differences in multiple myeloma biology but not clinical outcomes: results from 3894 patients in the myeloma XI trial. Clin Lymphoma Myeloma Leuk 21(10):667\u2013675. https:\/\/doi.org\/10.1016\/j.clml.2021.04.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2130_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canep.2019.02.010","volume":"59","author":"K Bora","year":"2019","unstructured":"Bora K (2019) Distribution of multiple myeloma in india: heterogeneity in incidence across age, sex, and geography. Cancer Epidemiol 59:215\u2013220. https:\/\/doi.org\/10.1016\/j.canep.2019.02.010","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"2130_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3324\/haematol.2016.150896","volume":"102","author":"M Ghermezi","year":"2017","unstructured":"Ghermezi M, Li M, Vardanyan S, Harutyunyan NM, Gottlieb J, Berenson A et al (2017) Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients. Haematologica 102(4):785. https:\/\/doi.org\/10.3324\/haematol.2016.150896","journal-title":"Haematologica"},{"issue":"12","key":"2130_CR15","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1128\/mcb.21.12.4067-4074.2001","volume":"21","author":"S Xu","year":"2001","unstructured":"Xu S, Lam KP (2001) B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 21(12):4067\u20134074. https:\/\/doi.org\/10.1128\/mcb.21.12.4067-4074.2001","journal-title":"Mol Cell Biol"},{"key":"2130_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.leukres.2019.04.008","volume":"81","author":"H Chen","year":"2019","unstructured":"Chen H, Li M, Xu N, Ng N, Sanchez E, Soof CM et al (2019) Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells. Leuk Res 81:62\u201366. https:\/\/doi.org\/10.1016\/j.leukres.2019.04.008","journal-title":"Leuk Res"},{"issue":"1","key":"2130_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12967-022-03285-y","volume":"20","author":"ST Nobari","year":"2022","unstructured":"Nobari ST, Nojadeh JN, Talebi M (2022) B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages. J Transl Med 20(1):82. https:\/\/doi.org\/10.1186\/s12967-022-03285-y","journal-title":"J Transl Med"},{"key":"2130_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11523-019-00666-0","volume":"14","author":"KA Udd","year":"2019","unstructured":"Udd KA, Bujarski S, Wirtschafter E, Spektor TM, Ghermezi M, Rassenti LZ et al (2019) Plasma B-cell maturation antigen levels are elevated and correlate with disease activity in patients with chronic lymphocytic leukemia. Target Oncol 14:551\u2013561. https:\/\/doi.org\/10.1007\/s11523-019-00666-0","journal-title":"Target Oncol"},{"issue":"23","key":"2130_CR19","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1182\/blood.V126.23.1778.1778","volume":"126","author":"S Vardanyan","year":"2015","unstructured":"Vardanyan S, Meid K, Udd KA, Wang J, Li M, Sanchez E et al (2015) Serum levels of B-Cell maturation antigen are elevated in waldenstr\u00f6m\u2019s macroglobulinemia patients and correlate with disease status and conventional M-Protein and IgM levels. Blood 126(23):1778. https:\/\/doi.org\/10.1182\/blood.V126.23.1778.1778","journal-title":"Blood"},{"issue":"6","key":"2130_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41408-020-0337-y","volume":"10","author":"A Dogan","year":"2020","unstructured":"Dogan A, Siegel D, Tran N, Fu A, Fowler J, Belani R et al (2020) B-cell maturation antigen expression across hematologic cancers: a systematic literature review. Blood Cancer J 10(6):73. https:\/\/doi.org\/10.1038\/s41408-020-0337-y","journal-title":"Blood Cancer J"},{"issue":"3","key":"2130_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cei\/uxae043","volume":"217","author":"P Guo","year":"2024","unstructured":"Guo P, Wang Y, He H, Chen D, Liu J, Qiang W et al (2024) Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma. Clin Exp Immunol 217(3):221\u2013232. https:\/\/doi.org\/10.1093\/cei\/uxae043","journal-title":"Clin Exp Immunol"},{"key":"2130_CR22","doi-asserted-by":"publisher","first-page":"1611171","DOI":"10.3389\/pore.2023.1611171","volume":"29","author":"\u00c1 Wiedemann","year":"2023","unstructured":"Wiedemann \u00c1, Szita VR, Horv\u00e1th R, Szederjesi A, Seb\u0151 A, T\u00f3th AD et al (2023) Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma. Pathol Oncol Res 29:1611171. https:\/\/doi.org\/10.3389\/pore.2023.1611171","journal-title":"Pathol Oncol Res"},{"issue":"5","key":"2130_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1182\/blood.2024026028","volume":"145","author":"D Ikeda","year":"2025","unstructured":"Ikeda D, Aikawa S, Misono C, Oura M, Fujii F, Sakuma H, Toho M, Uehara A, Tabata R, Narita K, Takeuchi M (2025) Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma. Blood 145(5):526\u2013532","journal-title":"Blood"},{"issue":"6","key":"2130_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41408-021-00505-4","volume":"11","author":"A Visram","year":"2021","unstructured":"Visram A, Soof C, Rajkumar SV, Kumar SK, Bujarski S, Spektor TM et al (2021) Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients. Blood Cancer J 11(6):120. https:\/\/doi.org\/10.1038\/s41408-021-00505-4","journal-title":"Blood Cancer J"},{"issue":"2","key":"2130_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3892\/ijmm.2024.5468","volume":"55","author":"R Xing","year":"2024","unstructured":"Xing R, Wang M, Wang L, Pan M, Wang Y, Zhou H (2024) Clinical updates of B-cell maturation antigen-targeted therapy in multiple myeloma (MM) and relapsed\/refractory MM. Int J Mol Med 55(2):27. https:\/\/doi.org\/10.3892\/ijmm.2024.5468","journal-title":"Int J Mol Med"},{"key":"2130_CR26","unstructured":"Song J, Chiang CH, Esagian S, Kim G, Chi KY, Chang Y, Parker T, Mehta AK (2020) Teclistamab versus B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis. Haematologica"},{"issue":"1","key":"2130_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40364-024-00634-5","volume":"12","author":"F Nasiri","year":"2024","unstructured":"Nasiri F, Asaadi Y, Mirzadeh F, Abdolahi S, Molaei S, Gavgani SP, Rahbarizadeh F (2024) Updates on CAR T cell therapy in multiple myeloma. Biomark Res 12(1):102","journal-title":"Biomark Res"},{"issue":"6","key":"2130_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jtct.2022.03.005","volume":"28","author":"S Josyula","year":"2022","unstructured":"Josyula S, Pont MJ, Dasgupta S, Song X, Thomas S, Pepper G, Keane-Candib J, Stevens-Ayers TL, Ochs HD, Boeckh MJ, Riddell SR (2022) Pathogen-specific humoral immunity and infections in B cell maturation antigen-directed chimeric antigen receptor T cell therapy recipients with multiple myeloma. Transplantation Cell Therapy 28(6):304\u2013e1","journal-title":"Transplantation Cell Therapy"},{"issue":"6","key":"2130_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/bjh.16673","volume":"192","author":"S Jew","year":"2021","unstructured":"Jew S, Bujarski S, Soof C, Chen H, Safaie T, Li M et al (2021) Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients. Br J Haematol 192(6):1064\u20131067. https:\/\/doi.org\/10.1111\/bjh.16673","journal-title":"Br J Haematol"},{"issue":"20","key":"2130_CR30","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/sim.2177","volume":"24","author":"C Jennen-Steinmetz","year":"2005","unstructured":"Jennen-Steinmetz C, Wellek S (2005) A new approach to sample size calculation for reference interval studies. Stat Med 24(20):3199\u20133212. https:\/\/doi.org\/10.1002\/sim.2177","journal-title":"Stat Med"},{"key":"2130_CR31","volume-title":"CLSI document EP28-A3c","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Defining, establishing, and verifying reference intervals in the clinical laboratory: approved guideline \u2013 Third edition. CLSI document EP28-A3c. CLSI, Wayne, PA"},{"key":"2130_CR32","volume-title":"Reference intervals: a user\u2019s guide","author":"PS Horn","year":"2005","unstructured":"Horn PS, Pesce AJ (2005) Reference intervals: a user\u2019s guide. American Association for Clinical Chemistry, Washington DC"},{"issue":"1","key":"2130_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/clinchem\/32.1.76","volume":"32","author":"TJ Sinton","year":"1986","unstructured":"Sinton TJ, Cowley DM, Bryant SJ (1986) Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem 32(1):76\u201379. https:\/\/doi.org\/10.1093\/clinchem\/32.1.76","journal-title":"Clin Chem"},{"issue":"6","key":"2130_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1365-2141.2012.09241.x","volume":"158","author":"E Sanchez","year":"2012","unstructured":"Sanchez E, Li M, Kitto A, Li J, Wang CS, Kirk DT et al (2012) Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. Br J Haematol 158(6):727\u2013738. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09241.x","journal-title":"Br J Haematol"},{"issue":"4","key":"2130_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ajh.27225","volume":"99","author":"BA Costa","year":"2024","unstructured":"Costa BA, Ortiz RJ, Lesokhin AM, Richter J (2024) Soluble B-cell maturation antigen in multiple myeloma. Am J Hematol 99(4):727\u2013738","journal-title":"Am J Hematol"},{"issue":"1","key":"2130_CR36","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/ncomms8333","volume":"6","author":"SA Laurent","year":"2015","unstructured":"Laurent SA, Hoffmann FS, Kuhn PH, Cheng Q, Chu Y, Schmidt-Supprian M, Hauck SM, Schuh E, Krumbholz M, R\u00fcbsamen H, Wanngren J (2015) \u03b3-Secretase directly sheds the survival receptor BCMA from plasma cells. Nat Commun 6(1):7333","journal-title":"Nat Commun"},{"issue":"6","key":"2130_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/cyto.b.22099","volume":"102","author":"H Sriram","year":"2022","unstructured":"Sriram H, Kunjachan F, Khanka T, Gawai S, Ghogale S, Deshpande N et al (2022) Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from the Indian Subcontinent. Cytometry B Clin Cytom 102(6):462\u2013470","journal-title":"Cytometry B Clin Cytom"},{"key":"2130_CR38","unstructured":"International Agency for Research on Cancer GLOBOCAN 2022. World Health Organization. Available from: https:\/\/gco.iarc.who.int\/today\/en\/dataviz\/tables"},{"key":"2130_CR39","unstructured":"International Agency for Research on Cancer GLOBOCAN 2022. World Health Organization. Available from: https:\/\/gco.iarc.who.int\/today"},{"key":"2130_CR40","unstructured":"Regional Cancer Centre Thiruvananthapuram. Annual Report 2021\u201322. Thiruvananthapuram, Kerala, India. Available from https:\/\/www.rcctvm.gov.in\/pdf\/annualreports\/RCC_AR_2021-22"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-025-02130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12288-025-02130-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-025-02130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:07:38Z","timestamp":1781978858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12288-025-02130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1007\/s12288-025-02130-8","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}